Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qiagen NV

46.55
0.0000
Post-market: 46.550.00000.00%16:19 EDT
Volume:870.34K
Turnover:40.54M
Market Cap:10.08B
PE:110.70
High:46.81
Open:46.50
Low:46.25
Close:46.55
Loading ...

Qiagen - H. Rusckowski To Succeed Lawrence A. Rosen As Chairman Of Supervisory Board Following AGM

Reuters
·
08 May

Qiagen NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Qiagen Q1 Adjusted Earnings, Revenue Rise; New $500 Million Stock Buyback Planned

MT Newswires Live
·
08 May

Earnings Flash (QGEN) QIAGEN Q1 Revenue $483 Million Vs. FactSet Est. $468.9 Million

MT Newswires Live
·
08 May

Earnings Flash (QGEN) QIAGEN Q1 Adjusted EPS $0.55 Vs. FactSet Est. $0.50

MT Newswires Live
·
08 May

Qiagen Q1 Adjusted EPS USD 0.55

Reuters
·
08 May

Qiagen Q1 Adj. EPS $0.55 Misses $0.56 Estimate, Sales $483.00M Miss $507.25M Estimate

Benzinga
·
08 May

Qiagen Plans to Initiate Dividend Payments

MT Newswires Live
·
07 May

Qiagen To Propose Initiation Of Annual Cash Dividend At AGM

Reuters
·
07 May

Press Release: QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

Dow Jones
·
07 May

Qiagen NV expected to post earnings of 50 cents a share - Earnings Preview

Reuters
·
06 May

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Zacks
·
02 May

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
02 May

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
30 Apr

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

Business Wire
·
30 Apr

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

Zacks
·
29 Apr

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

Business Wire
·
23 Apr

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?

Simply Wall St.
·
23 Apr

Qiagen Is Maintained at Neutral by Baird

Dow Jones
·
21 Apr

Qiagen price target raised to $43 from $42 at Baird

TIPRANKS
·
21 Apr